» Articles » PMID: 33411772

Influence of L-lactate and Low Glucose Concentrations on the Metabolism and the Toxin Formation of Clostridioides Difficile

Overview
Journal PLoS One
Date 2021 Jan 7
PMID 33411772
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The virulence of Clostridioides difficile (formerly Clostridium difficile) is mainly caused by its two toxins A and B. Their formation is significantly regulated by metabolic processes. Here we investigated the influence of various sugars (glucose, fructose, mannose, trehalose), sugar derivatives (mannitol and xylitol) and L-lactate on toxin synthesis. Fructose, mannose, trehalose, mannitol and xylitol in the growth medium resulted in an up to 2.2-fold increase of secreted toxin. Low glucose concentration of 2 g/L increased the toxin concentration 1.4-fold compared to growth without glucose, while high glucose concentrations in the growth medium (5 and 10 g/L) led to up to 6.6-fold decrease in toxin formation. Transcriptomic and metabolic investigation of the low glucose effect pointed towards an inactive CcpA and Rex regulatory system. L-lactate (500 mg/L) significantly reduced extracellular toxin formation. Transcriptome analyses of the later process revealed the induction of the lactose utilization operon encoding lactate racemase (larA), electron confurcating lactate dehydrogenase (CDIF630erm_01321) and the corresponding electron transfer flavoprotein (etfAB). Metabolome analyses revealed L-lactate consumption and the formation of pyruvate. The involved electron confurcation process might be responsible for the also observed reduction of the NAD+/NADH ratio which in turn is apparently linked to reduced toxin release from the cell.

Citing Articles

Unveiling the inhibition mechanism of by multiomics approach.

Jo S, Jeon H, Song W, Lee J, Kwon J, Park J Front Microbiol. 2023; 14:1293149.

PMID: 38029200 PMC: 10663266. DOI: 10.3389/fmicb.2023.1293149.


Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation.

Tubau-Juni N, Bassaganya-Riera J, Leber A, Alva S, Baker R, Hontecillas R Sci Rep. 2023; 13(1):14708.

PMID: 37679643 PMC: 10485029. DOI: 10.1038/s41598-023-41847-2.


Network analysis of toxin production in Clostridioides difficile identifies key metabolic dependencies.

Powers D, Jenior M, Kolling G, Papin J PLoS Comput Biol. 2023; 19(4):e1011076.

PMID: 37099624 PMC: 10166488. DOI: 10.1371/journal.pcbi.1011076.


Characterizing metabolic drivers of infection with activity-based hydrazine probes.

Bustin K, Abbas A, Wang X, Abt M, Zackular J, Matthews M Front Pharmacol. 2023; 14:1074619.

PMID: 36778002 PMC: 9908766. DOI: 10.3389/fphar.2023.1074619.


Gut associated metabolites and their roles in pathogenesis.

Aguirre A, Sorg J Gut Microbes. 2022; 14(1):2094672.

PMID: 35793402 PMC: 9450991. DOI: 10.1080/19490976.2022.2094672.


References
1.
Dannheim H, Riedel T, Neumann-Schaal M, Bunk B, Schober I, Sproer C . Manual curation and reannotation of the genomes of Clostridium difficile 630Δerm and C. difficile 630. J Med Microbiol. 2017; 66(3):286-293. DOI: 10.1099/jmm.0.000427. View

2.
Collins J, Robinson C, Danhof H, Knetsch C, van Leeuwen H, Lawley T . Dietary trehalose enhances virulence of epidemic Clostridium difficile. Nature. 2018; 553(7688):291-294. PMC: 5984069. DOI: 10.1038/nature25178. View

3.
Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, Di Masi A . Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel). 2016; 8(5). PMC: 4885049. DOI: 10.3390/toxins8050134. View

4.
Martin-Verstraete I, Peltier J, Dupuy B . The Regulatory Networks That Control Clostridium difficile Toxin Synthesis. Toxins (Basel). 2016; 8(5). PMC: 4885068. DOI: 10.3390/toxins8050153. View

5.
Neumann-Schaal M, Jahn D, Schmidt-Hohagen K . Metabolism the Difficile Way: The Key to the Success of the Pathogen . Front Microbiol. 2019; 10:219. PMC: 6384274. DOI: 10.3389/fmicb.2019.00219. View